Studies sought to evaluate 8-week efficacy and safety of RUX cream in patients with atopic dermatitis.
Learn more at the Journal of the American Academy of Dermatology.
Ruxolitinib cream: Assessing efficacy and safety for the treatment of atopic dermatitis
